Medication info
Versace Tablet 80/5mg

Versace Tablet 80/5mg

Prescription medicationOral
Ingredient · strength
Telmisartan›80mg / 1 tabletAmlodipine Besylate›6.935mg / 1 tablet
Manufacturer / importer
Samik Pharmaceutical Co., Ltd.
Appearance
White to yellowish and pale blue, biconvex, oval-shaped coated tablet
Packaging
30 tablets (10 tablets/PTP x 3), 30 tablets/bottle
Approval status
Active

MFDS item code 201606772 · Approved 2016.11.25 · Insurance code 644003820

Summary

Main use
Treatment of essential hypertension not controlled with monotherapy
Who takes it
Adults · Children
Adult dose
The recommended dose of this medicine is 1 tablet once daily, taken with water, with or without food. If possible, it is recommended to take it at the same time every day (e.g., in the morning). Before administering this medicine, it is recommended to adjust the dose using the individual components (amlodipine or telmisartan). However, if blood pressure is not controlled with the individual components as described below, switching directly to this medicine may be considered. - 40/5mg: For patients whose blood pressure is not adequately controlled with amlodipine 5mg or telmisartan 40mg. - 80/5mg: For patients whose blood pressure is not adequately controlled with amlodipine 5mg or this medicine 40/5mg. - 40/10mg: For patients whose blood pressure is not adequately controlled with amlodipine 10mg. ○ Patients with renal impairment: No dose adjustment is required in patients with mild or moderate renal impairment. In patients with severe renal impairment, however, it is recommended to start treatment at a low dose and increase the dose gradually. Periodic monitoring of serum potassium and creatinine levels is also recommended. Telmisartan is not removed by hemodialysis. ○ Patients with hepatic impairment: The daily dose of telmisartan in patients with mild or moderate hepatic impairment should not exceed 40 milligrams. ◦ Elderly patients: The usual amlodipine regimen is recommended for elderly patients, but caution should be exercised when increasing the dose. (See section ‘3. Patients requiring caution in administration’.) In patients aged 75 years and older, amlodipine clearance is reduced; therefore, start treatment at a low dose and increase the dose gradually.
Child dose
The safety and efficacy of this medicine have not been established in pediatric patients aged 18 years and younger; therefore, its use is not recommended.

Ingredients

Manufacturer
Samik Pharmaceutical Co., Ltd.

Efficacy & effects

Treatment of essential hypertension not controlled with monotherapy

  • Essential hypertension
View approved original text

This medication is used to more effectively lower blood pressure in patients with essential hypertension who are not adequately controlled with either amlodipine or telmisartan monotherapy.

How to take

Adult dose

The recommended dose of this medicine is 1 tablet once daily, taken with water, with or without food. If possible, it is recommended to take it at the same time every day (e.g., in the morning). Before administering this medicine, it is recommended to adjust the dose using the individual components (amlodipine or telmisartan). However, if blood pressure is not controlled with the individual components as described below, switching directly to this medicine may be considered. - 40/5mg: For patients whose blood pressure is not adequately controlled with amlodipine 5mg or telmisartan 40mg. - 80/5mg: For patients whose blood pressure is not adequately controlled with amlodipine 5mg or this medicine 40/5mg. - 40/10mg: For patients whose blood pressure is not adequately controlled with amlodipine 10mg. ○ Patients with renal impairment: No dose adjustment is required in patients with mild or moderate renal impairment. In patients with severe renal impairment, however, it is recommended to start treatment at a low dose and increase the dose gradually. Periodic monitoring of serum potassium and creatinine levels is also recommended. Telmisartan is not removed by hemodialysis. ○ Patients with hepatic impairment: The daily dose of telmisartan in patients with mild or moderate hepatic impairment should not exceed 40 milligrams. ◦ Elderly patients: The usual amlodipine regimen is recommended for elderly patients, but caution should be exercised when increasing the dose. (See section ‘3. Patients requiring caution in administration’.) In patients aged 75 years and older, amlodipine clearance is reduced; therefore, start treatment at a low dose and increase the dose gradually.

Child dose

The safety and efficacy of this medicine have not been established in pediatric patients aged 18 years and younger; therefore, its use is not recommended.

Precautions

This medication should not be used during pregnancy, especially in the second and third trimesters, as it may cause serious harm to the fetus. If pregnancy is confirmed, this medication should be discontinued as soon as possible. This medication should not be administered to patients with certain conditions, such as liver impairment, obstructive biliary disease, severe hypotension, or heart-related disorders. Additionally, it should not be taken by women who are pregnant, may become pregnant, or are breastfeeding. Caution is also required when administering this medication to patients with renal dysfunction or diabetes, as the risk of side effects may increase when used with certain medications. Symptoms such as dizziness or swelling may commonly occur during use, and if such symptoms arise, a consultation with a doctor is recommended. This medication works to lower blood pressure, which may cause hypotension, necessitating dosage adjustments if needed. Furthermore, while taking this medication, caution is needed when driving or operating hazardous machinery. In the event of an overdose, severe hypotension or cardiac issues may occur, necessitating immediate hospital care. This medication is not recommended for children, as its safety and efficacy in this population have not been sufficiently established. Store this medication out of reach of children and ensure it is kept dry.

Side effects

  • Dizziness
  • peripheral edema
  • syncope
  • upper respiratory infection
  • pharyngitis
  • sinusitis
  • urinary tract infection
  • cystitis
  • sepsis
  • anemia
Show 101 more
  • thrombocytopenia
  • eosinophilia
  • leukopenia
  • hypersensitivity
  • anaphylactic reaction
  • hyperkalemia
  • hypoglycemia
  • hyponatremia
  • hyperglycemia
  • depression
  • insomnia
  • mood changes
  • anxiety
  • confusion
  • drowsiness
  • headache
  • migraine
  • abnormal sensations
  • sensory loss
  • altered taste
  • tremor
  • extrapyramidal disorder
  • muscle rigidity
  • visual impairment
  • double vision
  • vertigo
  • tinnitus
  • palpitations
  • bradycardia
  • tachycardia
  • myocardial infarction
  • ventricular tachycardia
  • arrhythmia
  • atrial fibrillation
  • flushing
  • hypotension
  • orthostatic hypotension
  • vasculitis
  • cough
  • dyspnea
  • rhinitis
  • change in bowel habits
  • diarrhea
  • constipation
  • abdominal pain
  • dyspepsia
  • nausea
  • vomiting
  • dry mouth
  • gingival hyperplasia
  • abdominal discomfort
  • pancreatitis
  • gastritis
  • liver function abnormality
  • liver dysfunction
  • hepatitis
  • jaundice
  • increased liver enzymes
  • pruritus
  • hyperhidrosis
  • rash
  • alopecia
  • purpura
  • skin discoloration
  • eczema
  • erythema
  • angioedema
  • toxic skin rash
  • drug rash
  • urticaria
  • erythema multiforme
  • exfoliative dermatitis
  • Stevens-Johnson syndrome
  • photosensitivity reaction
  • joint swelling
  • muscle cramps
  • arthralgia
  • myalgia
  • low back pain
  • limb pain
  • tendon pain
  • renal dysfunction
  • urinary disorders
  • polyuria
  • nocturia
  • erectile dysfunction
  • gynecomastia
  • edema
  • asthenia
  • fatigue
  • chest pain
  • malaise
  • influenza-like illness
  • increased liver enzymes
  • elevated blood creatinine
  • weight gain
  • weight loss
  • elevated blood uric acid
  • increased serum creatine phosphokinase
  • decreased hemoglobin
  • interstitial lung disease

Not everyone experiences these, and they can vary from person to person.

Storage

This medication is sensitive to light and should be stored in a container that does not allow light to pass through. It is suggested to store it at room temperature between 1 and 30 degrees Celsius. Proper storage will help maintain the medication's efficacy for a longer period.

Appearance and packaging

Appearance

White to yellowish and pale blue, biconvex, oval-shaped coated tablet

Package unit

30 tablets (10 tablets/PTP x 3), 30 tablets/bottle

Same-ingredient medicines

Even with the same ingredient, strength, dosage form and how it is taken can differ.

Even with the same ingredient, the dose and directions can differ by strength and dosage form. Talk to a doctor or pharmacist before switching from a medication you are already taking.

Questions about this medicine

No questions yet.

For anything that needs medical judgment, consult a doctor or pharmacist.

Related searches

Search tags

Suggested searches

This drug information is based on data provided by the Korea Ministry of Food and Drug Safety.
Consult a doctor or pharmacist for accurate dosage, administration, and usage instructions.